![CO 2 -sensitive tRNA modification associated with human mitochondrial disease | Nature Communications CO 2 -sensitive tRNA modification associated with human mitochondrial disease | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-018-04250-4/MediaObjects/41467_2018_4250_Fig1_HTML.jpg)
CO 2 -sensitive tRNA modification associated with human mitochondrial disease | Nature Communications
![MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm](https://images.patentswarm.com/US20130123481A1/original.e911d4bd542fbee5f6551ef7439f5115873bf7279cac9ca355f4f6a1042ad001.png)
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
![3‐(3‐amino‐3‐carboxypropyl)‐5,6‐Dihydrouridine is one of two novel post‐transcriptional modifications in tRNALys(UUU) from Trypanosoma brucei - Krog - 2011 - The FEBS Journal - Wiley Online Library 3‐(3‐amino‐3‐carboxypropyl)‐5,6‐Dihydrouridine is one of two novel post‐transcriptional modifications in tRNALys(UUU) from Trypanosoma brucei - Krog - 2011 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/5478b066-699a-4532-99c1-6775556264ac/febs_8379_f1gam.jpg)
3‐(3‐amino‐3‐carboxypropyl)‐5,6‐Dihydrouridine is one of two novel post‐transcriptional modifications in tRNALys(UUU) from Trypanosoma brucei - Krog - 2011 - The FEBS Journal - Wiley Online Library
![MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm](https://images.patentswarm.com/US20130123481A1/original.4a37e31f233bb5b8528f1d053a1be5577434242d845ea6f57c3cec50259b6042.png)
MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF - US 2013 123,481 A1 - PatentSwarm
![3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm](https://images.patentswarm.com/US10676499B2/original.86dbbc17054ec33893f0b178c1c757c90edc691897b2ee76bf245d1f3945bcd1.png)
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
![WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search](https://s3-us-west-2.amazonaws.com/lens-resource/patent/WO/A1/2013052/2013052523/image/page/full/00000036.png)
WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search
![US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/a9/2e/9b/8e8fca5e342d4c/US07384924-20080610-C00046.png)
US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search](https://s3-us-west-2.amazonaws.com/lens-resource/patent/WO/A1/2013052/2013052523/image/page/full/00000038.png)
WO 2013/052523 A1 - Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof - The Lens - Free & Open Patent and Scholarly Search
Structure of intron-containing tRNA precursors. Analysis of solution conformation using chemical and enzymatic probes.
![US7547704B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7547704B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/ff/f3/62/f31ad5c3cb4a56/US07547704-20090616-C00028.png)
US7547704B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm](https://images.patentswarm.com/US10676499B2/original.79b2d2730927c60e6ac8de67d69b759fc0c55daa69e9fde05e886fbe560085f0.png)
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
![ChemInform Abstract: Palladium-Catalyzed Aryl Amination Reactions of 6-Bromo- and 6-Chloropurine Nucleosides. ChemInform Abstract: Palladium-Catalyzed Aryl Amination Reactions of 6-Bromo- and 6-Chloropurine Nucleosides.](https://www.researchgate.net/images/template/default_publication_preview_large.png)
ChemInform Abstract: Palladium-Catalyzed Aryl Amination Reactions of 6-Bromo- and 6-Chloropurine Nucleosides.
![US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/5c/09/28/640d215169028c/US07608600-20091027-C00007.png)
US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/74/ae/e0/1ab189ad06743a/US07384924-20080610-C00031.png)
US7384924B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm](https://images.patentswarm.com/US10676499B2/original.e68ec3b1c9917d84200cc9e6e27bb7778faa497c1b4d27fcb4e6fce149d12e94.png)
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm
![US7192936B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7192936B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/3c/9c/0d/57e8c9130022e9/US07192936-20070320-C00007.png)
US7192936B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents](https://patentimages.storage.googleapis.com/d5/2d/d1/86ef9611f06ada/US07608600-20091027-C00014.png)
US7608600B2 - Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections - Google Patents
![3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA - US 10,676,499 B2 - PatentSwarm](https://images.patentswarm.com/US10676499B2/original.a477bdbff70fa1aa6b802b6a8971740d8b8a25c75641d98400c06ee42541ad85.png)